APO Research

APO RESEARCH · REPORT

Adrenocorticotropic Hormone (ACTH)

Selected research

Industry Growth & Trends

Global Adrenocorticotropic Hormone (ACTH) Industry Growth and Trends Forecast to 2032

Market perspective

The global Adrenocorticotropic Hormone (ACTH) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Adrenocorticotropic Hormone (ACTH) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Adrenocorticotropic Hormone (ACTH) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adrenocorticotropic Hormone (ACTH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adrenocorticotropic Hormone (ACTH) include Novartis AG, Mylan N.V., Pfizer, Mallinckrodt and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Adrenocorticotropic Hormone (ACTH) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Adrenocorticotropic Hormone (ACTH) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Adrenocorticotropic Hormone (ACTH) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Adrenocorticotropic Hormone (ACTH).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Adrenocorticotropic Hormone (ACTH) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Adrenocorticotropic Hormone (ACTH) Market by Company

Novartis AG

Mylan N.V.

Pfizer

Mallinckrodt

Hikma Pharmaceuticals

Adrenocorticotropic Hormone (ACTH) Segment by Type

天然的

合成的

Adrenocorticotropic Hormone (ACTH) Segment by Application

医院药房

网上药房

零售药房

Adrenocorticotropic Hormone (ACTH) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adrenocorticotropic Hormone (ACTH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adrenocorticotropic Hormone (ACTH) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adrenocorticotropic Hormone (ACTH).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adrenocorticotropic Hormone (ACTH) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Adrenocorticotropic Hormone (ACTH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 天然的 Table 2. Major Company of 合成的 Table 3. Global Adrenocorticotropic Hormone (ACTH) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (K Units) Table 5. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Type (2021-2026) Table 8. Global Adrenocorticotropic Hormone (ACTH) Price by Type (2021-2026) & (US$/Unit) Table 9. Global Adrenocorticotropic Hormone (ACTH) Sales by Type (2027-2032) & (K Units) Table 10. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Adrenocorticotropic Hormone (ACTH) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Type (2027-2032) Table 13. Global Adrenocorticotropic Hormone (ACTH) Price by Type (2027-2032) & (US$/Unit) Table 14. North America Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (K Units) Table 15. North America Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (K Units) Table 17. Europe Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (K Units) Table 21. Latin America Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Type (2021-2026) & (US$ Million) Table 24. Adrenocorticotropic Hormone (ACTH) Industry Trends Table 25. Adrenocorticotropic Hormone (ACTH) Industry Drivers Table 26. Adrenocorticotropic Hormone (ACTH) Industry Opportunities and Challenges Table 27. Adrenocorticotropic Hormone (ACTH) Industry Restraints Table 28. Global Adrenocorticotropic Hormone (ACTH) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Adrenocorticotropic Hormone (ACTH) Revenue Market Share by Company (2021-2026) Table 30. Global Adrenocorticotropic Hormone (ACTH) Sales by Company (2021-2026) & (K Units) Table 31. Global Adrenocorticotropic Hormone (ACTH) Sales Share by Company (2021-2026) Table 32. Global Adrenocorticotropic Hormone (ACTH) Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Adrenocorticotropic Hormone (ACTH) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Adrenocorticotropic Hormone (ACTH) Major Company Production Sites and Headquarters Table 35. Global Adrenocorticotropic Hormone (ACTH) Company, Product Type & Application Table 36. Global Adrenocorticotropic Hormone (ACTH) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Adrenocorticotropic Hormone (ACTH) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Adrenocorticotropic Hormone (ACTH) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Adrenocorticotropic Hormone (ACTH) Sales by Region (2021-2026) & (K Units) Table 41. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Adrenocorticotropic Hormone (ACTH) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Region (2021-2026) Table 44. Global Adrenocorticotropic Hormone (ACTH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Adrenocorticotropic Hormone (ACTH) Sales by Region (2027-2032) & (K Units) Table 46. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Adrenocorticotropic Hormone (ACTH) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Region (2027-2032) Table 49. Global Adrenocorticotropic Hormone (ACTH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Adrenocorticotropic Hormone (ACTH) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (K Units) Table 52. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Application (2021-2026) Table 55. Global Adrenocorticotropic Hormone (ACTH) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Adrenocorticotropic Hormone (ACTH) Sales by Application (2027-2032) & (K Units) Table 57. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Adrenocorticotropic Hormone (ACTH) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Application (2027-2032) Table 60. Global Adrenocorticotropic Hormone (ACTH) Price by Application (2027-2032) & (US$/Unit) Table 61. North America Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (K Units) Table 62. North America Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (K Units) Table 64. Europe Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (K Units) Table 68. Latin America Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis AG Company Information Table 72. Novartis AG Business Overview Table 73. Novartis AG Adrenocorticotropic Hormone (ACTH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis AG Adrenocorticotropic Hormone (ACTH) Product Portfolio Table 75. Novartis AG Recent Development Table 76. Mylan N.V. Company Information Table 77. Mylan N.V. Business Overview Table 78. Mylan N.V. Adrenocorticotropic Hormone (ACTH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan N.V. Adrenocorticotropic Hormone (ACTH) Product Portfolio Table 80. Mylan N.V. Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Adrenocorticotropic Hormone (ACTH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Adrenocorticotropic Hormone (ACTH) Product Portfolio Table 85. Pfizer Recent Development Table 86. Mallinckrodt Company Information Table 87. Mallinckrodt Business Overview Table 88. Mallinckrodt Adrenocorticotropic Hormone (ACTH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Mallinckrodt Adrenocorticotropic Hormone (ACTH) Product Portfolio Table 90. Mallinckrodt Recent Development Table 91. Hikma Pharmaceuticals Company Information Table 92. Hikma Pharmaceuticals Business Overview Table 93. Hikma Pharmaceuticals Adrenocorticotropic Hormone (ACTH) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Hikma Pharmaceuticals Adrenocorticotropic Hormone (ACTH) Product Portfolio Table 95. Hikma Pharmaceuticals Recent Development Table 96. North America Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026) & (K Units) Table 98. North America Adrenocorticotropic Hormone (ACTH) Sales Market Share by Country (2021-2026) Table 99. North America Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Adrenocorticotropic Hormone (ACTH) Sales Market Share Forecast by Country (2027-2032) Table 101. North America Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Adrenocorticotropic Hormone (ACTH) Market Share by Country (2021-2026) Table 104. North America Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Adrenocorticotropic Hormone (ACTH) Market Share Forecast by Country (2027-2032) Table 106. Europe Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026) & (K Units) Table 108. Europe Adrenocorticotropic Hormone (ACTH) Sales Market Share by Country (2021-2026) Table 109. Europe Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Adrenocorticotropic Hormone (ACTH) Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Adrenocorticotropic Hormone (ACTH) Market Share by Country (2021-2026) Table 114. Europe Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Adrenocorticotropic Hormone (ACTH) Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share by Country (2021-2026) Table 124. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share Forecast by Country (2027-2032) Table 126. Latin America Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026) & (K Units) Table 128. Latin America Adrenocorticotropic Hormone (ACTH) Sales Market Share by Country (2021-2026) Table 129. Latin America Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Adrenocorticotropic Hormone (ACTH) Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Adrenocorticotropic Hormone (ACTH) Market Share by Country (2021-2026) Table 134. Latin America Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Adrenocorticotropic Hormone (ACTH) Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Share by Country (2021-2026) Table 144. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Adrenocorticotropic Hormone (ACTH) Distributors List Table 149. Adrenocorticotropic Hormone (ACTH) Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Adrenocorticotropic Hormone (ACTH) Image Figure 2. Global Adrenocorticotropic Hormone (ACTH) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adrenocorticotropic Hormone (ACTH) Market Size (2021-2032) & (US$ Million) Figure 4. Global Adrenocorticotropic Hormone (ACTH) Sales (2021-2032) & (K Units) Figure 5. 天然的 Image Figure 6. Global 天然的 Sales YoY Growth (2021-2032) & (K Units) Figure 7. 合成的 Image Figure 8. Global 合成的 Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Adrenocorticotropic Hormone (ACTH) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Adrenocorticotropic Hormone (ACTH) Market Share by Type 2025 VS 2032 Figure 11. North America Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Type in 2025 Figure 12. North America Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Type in 2025 Figure 13. Europe Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Adrenocorticotropic Hormone (ACTH) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. 医院药房 Image Figure 24. Global 医院药房 Sales YoY Growth (2021-2032) & (K Units) Figure 25. 网上药房 Image Figure 26. Global 网上药房 Sales YoY Growth (2021-2032) & (K Units) Figure 27. 零售药房 Image Figure 28. Global 零售药房 Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Adrenocorticotropic Hormone (ACTH) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Adrenocorticotropic Hormone (ACTH) Market Share by Application 2025 VS 2032 Figure 31. North America Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Application in 2025 Figure 32. North America Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Application in 2025 Figure 33. Europe Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Market Share in Value by Application in 2025 Figure 41. North America Adrenocorticotropic Hormone (ACTH) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Adrenocorticotropic Hormone (ACTH) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Adrenocorticotropic Hormone (ACTH) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Adrenocorticotropic Hormone (ACTH) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Adrenocorticotropic Hormone (ACTH) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Adrenocorticotropic Hormone (ACTH) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Adrenocorticotropic Hormone (ACTH) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Adrenocorticotropic Hormone (ACTH) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Adrenocorticotropic Hormone (ACTH) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Adrenocorticotropic Hormone (ACTH) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Adrenocorticotropic Hormone (ACTH) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 天然的
  • 合成的
Applications
  • 医院药房
  • 网上药房
  • 零售药房
Companies covered
  • Novartis AG
  • Mylan N.V.
  • Pfizer
  • Mallinckrodt
  • Hikma Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Adrenocorticotropic Hormone (ACTH) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Adrenocorticotropic Hormone (ACTH) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Adrenocorticotropic Hormone (ACTH) Market by Type
  6. 1.3.1 天然的
  7. 1.3.2 合成的
  8. 1.4 Global Adrenocorticotropic Hormone (ACTH) Market Size by Type
  9. 1.4.1 Global Adrenocorticotropic Hormone (ACTH) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Adrenocorticotropic Hormone (ACTH) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Adrenocorticotropic Hormone (ACTH) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Adrenocorticotropic Hormone (ACTH) Industry Trends
  2. 2.2 Adrenocorticotropic Hormone (ACTH) Industry Drivers
  3. 2.3 Adrenocorticotropic Hormone (ACTH) Industry Opportunities and Challenges
  4. 2.4 Adrenocorticotropic Hormone (ACTH) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Adrenocorticotropic Hormone (ACTH) Revenue (2021-2026)
  2. 3.2 Global Top Players by Adrenocorticotropic Hormone (ACTH) Sales (2021-2026)
  3. 3.3 Global Top Players by Adrenocorticotropic Hormone (ACTH) Price (2021-2026)
  4. 3.4 Global Adrenocorticotropic Hormone (ACTH) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adrenocorticotropic Hormone (ACTH) Major Company Production Sites & Headquarters
  6. 3.6 Global Adrenocorticotropic Hormone (ACTH) Company, Product Type & Application
  7. 3.7 Global Adrenocorticotropic Hormone (ACTH) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adrenocorticotropic Hormone (ACTH) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adrenocorticotropic Hormone (ACTH) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adrenocorticotropic Hormone (ACTH) Tier 1, Tier 2, and Tier 3
4 Adrenocorticotropic Hormone (ACTH) Regional Status and Outlook
  1. 4.1 Global Adrenocorticotropic Hormone (ACTH) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Adrenocorticotropic Hormone (ACTH) Historic Market Size by Region
  3. 4.2.1 Global Adrenocorticotropic Hormone (ACTH) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Adrenocorticotropic Hormone (ACTH) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Adrenocorticotropic Hormone (ACTH) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Adrenocorticotropic Hormone (ACTH) Forecasted Market Size by Region
  7. 4.3.1 Global Adrenocorticotropic Hormone (ACTH) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Adrenocorticotropic Hormone (ACTH) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Adrenocorticotropic Hormone (ACTH) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Adrenocorticotropic Hormone (ACTH) by Application
  1. 5.1 Adrenocorticotropic Hormone (ACTH) Market by Application
  2. 5.1.1 医院药房
  3. 5.1.2 网上药房
  4. 5.1.3 零售药房
  5. 5.2 Global Adrenocorticotropic Hormone (ACTH) Market Size by Application
  6. 5.2.1 Global Adrenocorticotropic Hormone (ACTH) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Adrenocorticotropic Hormone (ACTH) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Adrenocorticotropic Hormone (ACTH) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Adrenocorticotropic Hormone (ACTH) Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Mylan N.V.
  8. 6.2.1 Mylan N.V. Company Information
  9. 6.2.2 Mylan N.V. Business Overview
  10. 6.2.3 Mylan N.V. Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan N.V. Adrenocorticotropic Hormone (ACTH) Product Portfolio
  12. 6.2.5 Mylan N.V. Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Adrenocorticotropic Hormone (ACTH) Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Mallinckrodt
  20. 6.4.1 Mallinckrodt Company Information
  21. 6.4.2 Mallinckrodt Business Overview
  22. 6.4.3 Mallinckrodt Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mallinckrodt Adrenocorticotropic Hormone (ACTH) Product Portfolio
  24. 6.4.5 Mallinckrodt Recent Developments
  25. 6.5 Hikma Pharmaceuticals
  26. 6.5.1 Hikma Pharmaceuticals Company Information
  27. 6.5.2 Hikma Pharmaceuticals Business Overview
  28. 6.5.3 Hikma Pharmaceuticals Adrenocorticotropic Hormone (ACTH) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hikma Pharmaceuticals Adrenocorticotropic Hormone (ACTH) Product Portfolio
  30. 6.5.5 Hikma Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Adrenocorticotropic Hormone (ACTH) Sales by Country
  2. 7.1.1 North America Adrenocorticotropic Hormone (ACTH) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026)
  4. 7.1.3 North America Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Adrenocorticotropic Hormone (ACTH) Market Size by Country
  6. 7.2.1 North America Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026)
  8. 7.2.3 North America Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Adrenocorticotropic Hormone (ACTH) Sales by Country
  2. 8.1.1 Europe Adrenocorticotropic Hormone (ACTH) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026)
  4. 8.1.3 Europe Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Adrenocorticotropic Hormone (ACTH) Market Size by Country
  6. 8.2.1 Europe Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales by Country
  2. 9.1.1 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size by Country
  6. 9.2.1 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Adrenocorticotropic Hormone (ACTH) Sales by Country
  2. 10.1.1 South America Adrenocorticotropic Hormone (ACTH) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026)
  4. 10.1.3 South America Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Adrenocorticotropic Hormone (ACTH) Market Size by Country
  6. 10.2.1 South America Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026)
  8. 10.2.3 South America Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Country
  2. 11.1.1 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size by Country
  6. 11.2.1 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Adrenocorticotropic Hormone (ACTH) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Adrenocorticotropic Hormone (ACTH) Value Chain Analysis
  2. 12.1.1 Adrenocorticotropic Hormone (ACTH) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Adrenocorticotropic Hormone (ACTH) Production Mode & Process
  7. 12.2 Adrenocorticotropic Hormone (ACTH) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Adrenocorticotropic Hormone (ACTH) Distributors
  10. 12.2.3 Adrenocorticotropic Hormone (ACTH) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research